ACARIX vs GETI-B: Side-by-Side Comparison
Compare Acarix A/S (ACARIX) and Getinge AB ser. B (GETI-B) side by side: market cap SEK 303.41M vs SEK 54.43B. Financials, growth and model signals on Bullrun.
| Metric | ACARIX | GETI-B |
|---|---|---|
| Company | Acarix A/S | Getinge AB ser. B |
| Country / Exchange | Sweden · ST | Sweden · ST |
| Sector | Healthcare | Healthcare |
| Industry | Medical Devices | Medical Devices |
| Market cap | SEK 303.41M | SEK 54.43B |
| P/E ratio | — | 23.1 |
| Dividend yield | — | 2.42% |
| Valuation model | — | 14.1% undervalued |
| Revenue (latest FY) | — | SEK 34.76B |
| Revenue growth YoY | — | +9.2% |
| Net income | — | SEK 1.65B |
| Gross margin | — | 46.5% |
| Diluted EPS | — | 6.01 |